Update on pathology of antibody-mediated rejection in the lung allograft

Current Opinion in Organ Transplantation

Volumn 19, Issue 3, 2014, Pages 303-308

  Wallace, William D ^a   Weigt, Sam S ^a   Farver, Carol F ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

antibody mediated rejection; C4d; donor specific antibodies; humoral rejection; lung transplantation; pathology

Indexed keywords

COMPLEMENT COMPONENT C4D;

ACUTE LUNG INJURY; ALLOGRAFT; ANTIBODY MEDIATED REJECTION; COMPLEMENT DEPOSITION; HISTOPATHOLOGY; HUMAN; HYPERACUTE GRAFT REJECTION; IMMUNOPATHOLOGY; LUNG; LUNG ALLOGRAFT; LUNG CAPILLARY; MEDICAL SOCIETY; NEUTROPHIL; REVIEW;

ALLOGRAFTS; AUTOANTIBODIES; BIOLOGICAL MARKERS; COMPLEMENT C4B; GRAFT REJECTION; HUMANS; ISOANTIBODIES; LUNG TRANSPLANTATION; PEPTIDE FRAGMENTS; TISSUE DONORS;

EID: 84900841273     PISSN: 10872418     EISSN: 15317013     Source Type: Journal    
DOI: 10.1097/MOT.0000000000000079     Document Type: Review

References (39)

1. Berry G, Burke M, Andersen C, et al. Pathology of pulmonary antibodymediated rejection: 2012 update from the Pathology Council of the ISHLT. J Heart Lung Transplant 2013; 32:14-21
2. Daoud AH, Betensley AD. Diagnosis and treatment of antibody mediated rejection in lung transplantation: A retrospective case series. Transpl Immunol 2013; 28:1-5
3. DeNicola MM, Weigt SS, Belperio JA, et al. Pathologic findings in lung allografts with anti-HLA antibodies. J Heart Lung Transplant 2013; 32: 326-332
4. Yousem SA, Zeevi A. The histopathology of lung allograft dysfunction associated with the development of donor-specific HLA alloantibodies. Am J Surg Pathol 2012; 36:987-992
5. Witt CA, Gaut JP, Yusen RD, et al. Acute antibody-mediated rejection after lung transplantation. J Heart Lung Transplant 2013; 32:1034-1040
6. Stewart S, Fishbein MC, Snell GI, et al. Revision of the 1996 Working Formulation for the standardization of nomenclature in the diagnosis of lung rejection. J Heart Lung Transplant 2007; 26:1229-1242
7. Haas M, Sis B, Racusen LC, et al. Banff 2013 meeting report: inclusion of C4d-negative antibody-mediated rejection and antibody-Associated arterial lesions. Am J Transplant 2014; 14:272-283
8. Stewart S, Winters GL, Fishbein MC, et al. Revision of the 1990 Working Formulation for the standardization of nomenclature in the diagnosis of heart rejection. J Heart Lung Transplant 2005; 24:1710-1720
9. Montgomery RA, Cozzi E, West LJ, Warren DS. Humoral immunity and antibody-mediated rejection in solid organ transplantation. Semin Immunol 2011; 23:224-234
10. Joudeh A, Saliba KA, Topping KA, Sis B. Pathologic basis of antibodymediated organ transplant rejection: from pathogenesis to diagnosis. Curr Opin Organ Transplant 2013; 18:478-485
11. Berry GJ, Angelini A, Burke MM, et al. The ISHLT working formulation for pathologic diagnosis of antibody-mediated rejection in heart transplantation: evolution and current status (2005-2011). J Heart Lung Transplant 2011; 30:601-611
12. Hachem R. Antibody-mediated lung transplant rejection. Curr Respir Care Rep 2012; 1:157-161
13. Astor TL, Galantowicz M, Phillips A, et al. Pulmonary capillaritis as a manifestation of acute humoral allograft rejection following infant lung transplantation. Am J Transplant 2009; 9:409-412
14. Girnita AL, Lee TM, McCurry KR, et al. Antihuman leukocyte antigen antibodies, vascular C4d deposition and increased soluble C4d in bronchoalveolar lavage of lung allografts. Transplantation 2008; 86:342-347
15. Hachem RR. Lung allograft rejection: diagnosis and management. Curr Opin Organ Transplant 2009; 14:477-482
16. Ionescu DN, Girnita AL, Zeevi A, et al. C4d deposition in lung allografts is associated with circulating anti-HLA alloantibody. Transpl Immunol 2005; 15:63-68
17. Martinu T, Pavlisko EN, Chen DF, Palmer SM. Acute allograft rejection: cellular and humoral processes. Clin Chest Med 2011; 32:295-310
18. McManigle W, Pavlisko EN, Martinu T. Acute cellular and antibody-mediated allograft rejection. Semin Respir Crit Care Med 2013; 34:320-335
19. Morrell MR, Patterson GA, Trulock EP, Hachem RR. Acute antibody-mediated rejection after lung transplantation. J Heart Lung Transplant 2009; 28:96-100
20. Takemoto SK, Zeevi A, Feng S, et al. National conference to assess antibodymediated rejection in solid organ transplantation. Am J Transplant 2004; 4:1033-1041
21. Astor TL, Weill D, Cool C, et al. Pulmonary capillaritis in lung transplant recipients: Treatment and effect on allograft function. J Heart Lung Transplant 2005; 24:2091-2097
22. Witt CA, Gaut JP, Yusen RD, et al. Acute antibody-mediated rejection after lung transplantation. J Heart Lung Transplant 2013; 32:1034-1040
23. Magro CM, Abbas AE, Seilstad K, et al. C3d and the septal microvasculature as a predictor of chronic lung allograft dysfunction. Hum Immunol 2006; 67:274-283
24. Westall GP, Snell GI, McLean C, et al. C3d and C4d deposition early after lung transplantation. J Heart Lung Transplant 2008; 27:722-728
25. Magro CM, Deng A, Pope-Harman A, et al. Humorally mediated posttransplantation septal capillary injury syndrome as a common form of pulmonary allograft rejection: A hypothesis. Transplantation 2002; 74:1273-1280
26. Wallace WD, Reed EF, Ross D, et al. C4d staining of pulmonary allograft biopsies: An immunoperoxidase study. J Heart Lung Transplant 2005; 24:1565-1570
27. Hachem RR, Yusen RD, Meyers BF, et al. Antihuman leukocyte antigen antibodies and preemptive antibody-directed therapy after lung transplantation. J Heart Lung Transplant 2010; 29:973-980
28. Girnita AL, Duquesnoy R, Yousem SA, et al. HLA-specific antibodies are risk factors for lymphocytic bronchiolitis and chronic lung allograft dysfunction. Am J Transplant 2005; 5:131-138
29. Lobo LJ, Aris RM, Schmitz J, Neuringer IP. Donor-specific antibodies are associated with antibody-mediated rejection, acute cellular rejection, bronchiolitis obliterans syndrome, and cystic fibrosis after lung transplantation. J Heart Lung Transplant 2013; 32:70-77
30. Sis B, Halloran PF. Endothelial transcripts uncover a previously unknown phenotype: C4d-negative antibody-mediated rejection. Curr Opin Organ Transplant 2010; 15:42-48
31. Masson E, Stern M, Chabod J, et al. Hyperacute rejection after lung transplantation caused by undetected low-titer anti-HLA antibodies. J Heart Lung Transplant 2007; 26:642-645
32. Choi JK, Kearns J, Palevsky HI, et al. Hyperacute rejection of a pulmonary allograft. Immediate clinical and pathologic findings. Am J Respir Crit Care Med 1999; 160:1015-1018
33. Bittner HB, Dunitz J, Hertz M, et al. Hyperacute rejection in single lung transplantation - case report of successful management by means of plasmapheresis and antithymocyte globulin treatment. Transplantation 2001; 71:649-651
34. Martinu T, Chen DF, Palmer SM. Acute rejection and humoral sensitization in lung transplant recipients. Proc Am Thorac Soc 2009; 6:54-65
35. Racusen LC, Colvin RB, Solez K, et al. Antibody-mediated rejection criteria - An addition to the Banff 97 classification of renal allograft rejection. Am J Transplant 2003; 3:708-714
36. Badesch DB, Zamora M, Fullerton D, et al. Pulmonary capillaritis: A possible histologic form of acute pulmonary allograft rejection. J Heart Lung Transplant 1998; 17:415-422
37. Girnita AL, McCurry KR, Iacono AT, et al. HLA-specific antibodies are associated with high-grade and persistent-recurrent lung allograft acute rejection. J Heart Lung Transplant 2004; 23:1135-1141
38. Mauiyyedi S, Crespo M, Collins AB, et al. Acute humoral rejection in kidney transplantation. II. Morphology, immunopathology, and pathologic classification. J Am Soc Nephrol 2002; 13:779-787
39. Roberts JA, Barrios R, Cagle PT, et al. The presence of anti-HLA donorspecific antibodies in lung allograft recipients does not correlate with C4d immunofluorescence in transbronchial biopsy specimens. Arch Pathol Lab Med 2013. [Epub ahead of print]